Arcturus Therapeutics Expands Operations Campus In San Diego, California
11/04/2014
Founded in 2013, Arcturus Therapeutics is focused on RNA medicines for the treatment of rare diseases. Arcturus has developed a novel, potent and safe RNA Therapeutics platform called LUNAR, a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, antisense, and microRNA oligotherapeutics. The company owns Unlocked Nucleic Acid chemistry technology and patent portfolio enabling the targeting of any gene in the human genome.
"The Arcturus story began at the cutting edge Johnson and Johnson Innovation Center here in San Diego. Today, we are 'graduating' from the incubator space and moving into top-tier facilities that will enable us to execute our vision of bringing transformational life-saving RNA medicines to patients," said Joseph E. Payne, President/CEO of Arcturus Therapeutics, Inc. "We are expanding our work force and hiring key individuals to help us develop premier RNA medicines, such as our lead rare disease drug candidate, LUNAR-101, for treatment of transthyretin-mediated amyloidosis."
"San Diego is a city of innovation. Arcturus Therapeutics is an excellent example of the region's entrepreneurial spirit. Outstanding high-growth biotechnology companies like Arcturus are making us a global leader in technological breakthroughs while also providing high quality jobs for San Diegans here at home," said San Diego Mayor Kevin Faulconer.
Project Announcements
MMR Group Plans Lafayette Parish, Louisiana, Assembly Operations
10/14/2025
J.M. Smucker-Hostess Brands Expand Columbus, Georgia, Production Operations
10/14/2025
DMR Technologies Plans Lafayette Parish, Louisiana, Manufacturing Operations
10/14/2025
Swiss-Based Hitachi Energy Expands Varennes, Canada, Operations
10/14/2025
Underwood Ammo Plans Effingham County, Georgia, Manufacturing Operations
10/14/2025
Google Plans West Memphis, Arkansas, Data Center Operations
10/14/2025
Most Read
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025
-
Tariffs, Talent, and U.S. Expansion
Q3 2025
-
The Compliance Reckoning Is Here
Q3 2025
-
Around the Horn: Data Center Supply Chains — What's Next?
Q3 2025
-
Data Center Demand Stabilizes Amid Changing Market Forces
Q3 2025
-
Powering the Next Generation of Projects
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025